Evaluation of the effect of Microrelin in treatment of metastatic prostate cancer
Phase 1
- Conditions
- Prostate Cancer.Malignant neoplasm of prostate
- Registration Number
- IRCT201310229819N3
- Lead Sponsor
- Vice chancellor for research Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
All patients with metastatic prostate cancer without age limitation who are referred to urology clinic of Imam Khomeyni Hospital in 01.21.2014 until 01.21.2015 and accepted the term and condition of this study.
Exclusion criteria: Reluctance of patients to continue the study or in case of death
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PSA. Timepoint: Before intervention, one month after intervention, three months after intervention and six months after intervention. Method of measurement: ELIZA.;Serum Testosterone. Timepoint: Before intervention, one month after intervention, three months after intervention and six months after intervention. Method of measurement: ELIZA.
- Secondary Outcome Measures
Name Time Method oss of libido (Sexual desire was absent in all cases following castration) and Hot flash (As a subjective feeling of warmth in the head followed by objective perspiration, hot flashes are not life threatening but are among the most common side effects of androgen ablation). Timepoint: At every visit. Method of measurement: With history taking and physical exam.